相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clade-specific chromosomal rearrangements and loss of subtelomeric adhesins in Candida auris
Jose F. Munoz et al.
GENETICS (2021)
Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans
Andrew T. Nishimoto et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Mutations in TAC1B: a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris
Jeffrey M. Rybak et al.
MBIO (2020)
Tracing the Evolutionary History and Global Expansion of Candida auris Using Population Genomic Analyses
Nancy A. Chow et al.
MBIO (2020)
The Evolution of Azole Resistance in Candida albicans Sterol 14α-Demethylase (CYP51) through Incremental Amino Acid Substitutions
Andrew G. Warrilow et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Abrogation of Triazole Resistance upon Deletion of CDR1 in a Clinical Isolate of Candida auris
Jeffrey M. Rybak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Candida auris Clinical Isolates from South Korea: Identification, Antifungal Susceptibility, and Genotyping
Yong Jun Kwon et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2019)
Mutations in hmg1, Challenging the Paradigm of Clinical Triazole Resistance in Aspergillus fumigatus
Jeffrey M. Rybak et al.
MBIO (2019)
Emerging threat of triazole-resistant Aspergillus fumigatus
Jeffrey M. Rybak et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Trends in antifungal use in US hospitals, 2006-12
Snigdha Vallabhaneni et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Limited ERG11 Mutations Identified in Isolates of Candida au ris Directly Contribute to Reduced Azole Susceptibility
Kelley R. Healey et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
Shawn R. Lockhart et al.
CLINICAL INFECTIOUS DISEASES (2017)
The global problem of antifungal resistance: prevalence, mechanisms, and management
David S. Perlin et al.
LANCET INFECTIOUS DISEASES (2017)
Contribution of Clinically Derived Mutations in ERG11 to Azole Resistance in Candida albicans
Stephanie A. Flowers et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole
J. Lescar et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Gain-of-Function Mutations in UPC2 Are a Frequent Cause of ERG11 Upregulation in Azole-Resistant Clinical Isolates of Candida albicans
Stephanie A. Flowers et al.
EUKARYOTIC CELL (2012)
Candida auris sp nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital
Kazuo Satoh et al.
MICROBIOLOGY AND IMMUNOLOGY (2009)
A gain-of-function mutation in the transcription factor Upc2p causes Upregulation of ergosterol biosynthesis genes and increased Fluconazole resistance in a clinical Candida albicans isolate
Nico Dunkel et al.
EUKARYOTIC CELL (2008)
分享论文
